We are live on ! Find out more
KB

Kimelman & Baird Portfolio holdings

AUM $1.22B
1-Year Est. Return 11.47%
This Fund
S&P 500
This Quarter Est. Return
-2.9%
1 Year Est. Return
+11.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.22B
AUM Growth
-$86.4M
Cap. Flow
-$26.2M
Cap. Flow %
-2.15%
Top 10 Hldgs %
42.8%
Holding
275
New
12
Increased
27
Reduced
50
Closed
12

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.07M
2
CSCO icon
Cisco
CSCO
+$6.05M
3
NVDA icon
NVIDIA
NVDA
+$3M
4
TRV icon
Travelers Companies
TRV
+$2.49M
5
AXP icon
American Express
AXP
+$1.07M

Top Sells

Rank Stock Value
1
NSC icon
Norfolk Southern
NSC
+$16.9M
2
JPM icon
JPMorgan Chase
JPM
+$7.16M
3
MA icon
Mastercard
MA
+$4.01M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.2M
5
SOLS
Solstice Advanced Materials
SOLS
+$1.85M

Sector Composition

Rank Sector Weight
1 Industrials 20.74%
2 Financials 18.47%
3 Technology 18.41%
4 Consumer Discretionary 15.76%
5 Healthcare 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STE icon
51
Steris
STE
$20.9B
$2.8M 0.23%
12,666
-1,992
-14% -$487K
JNJ icon
52
Johnson & Johnson
JNJ
$634B
$2.55M 0.21%
10,450
+54
+0.5% +$12.6K
TRV icon
53
Travelers Companies
TRV
$80.8B
$2.48M 0.2%
+8,514
New +$2.49M
ABT icon
54
Abbott
ABT
$180B
$2.41M 0.2%
23,506
– –
GLD icon
55
SPDR Gold Trust
GLD
$131B
$2.32M 0.19%
5,390
– –
MRSH
56
Marsh
MRSH
$86.3B
$2.19M 0.18%
12,630
– –
LITE icon
57
Lumentum
LITE
$59.4B
$1.67M 0.14%
2,374
-100
-4% -$54.9K
KIM icon
58
Kimco Realty
KIM
$17.6B
$1.53M 0.13%
68,125
– –
MTX icon
59
Minerals Technologies
MTX
$2.31B
$1.53M 0.13%
21,532
– –
ECL icon
60
Ecolab
ECL
$75.6B
$1.51M 0.12%
5,658
– –
SXT icon
61
Sensient Technologies
SXT
$5.4B
$1.44M 0.12%
16,650
– –
EOG icon
62
EOG Resources
EOG
$78B
$1.36M 0.11%
9,400
-295
-3% -$35.8K
MDLZ icon
63
Mondelez International
MDLZ
$77.7B
$1.29M 0.11%
22,307
-300
-1% -$17.4K
PFE icon
64
Pfizer
PFE
$140B
$1.21M 0.1%
42,976
-1,915
-4% -$51K
PM icon
65
Philip Morris
PM
$301B
$1.21M 0.1%
7,297
– –
GEV icon
66
GE Vernova
GEV
$270B
$1.2M 0.1%
1,378
– –
SYY icon
67
Sysco
SYY
$39.7B
$1.18M 0.1%
16,599
– –
KR icon
68
Kroger
KR
$34.8B
$1.11M 0.09%
15,300
– –
GNR icon
69
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.75B
$1.08M 0.09%
14,500
– –
UL icon
70
Unilever
UL
$131B
$1.07M 0.09%
18,796
– –
NVS icon
71
Novartis
NVS
$295B
$1.05M 0.09%
6,850
– –
FNLC icon
72
First Bancorp
FNLC
$394M
$999K 0.08%
35,625
+1,500
+4% +$41.6K
CMCSA icon
73
Comcast
CMCSA
$79.7B
$998K 0.08%
34,778
– –
BMY icon
74
Bristol-Myers Squibb
BMY
$127B
$942K 0.08%
15,525
– –
VST icon
75
Vistra
VST
$55.1B
$932K 0.08%
6,200
– –
1 2
3
4 5

Similar funds

DPI
Diversified Portfolios Inc Bloomfield Hills, Michigan $1.22B AUM 11.83% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return
AG
Atairos Group Bryn Mawr, Pennsylvania $1.22B AUM 38.2% 1-Year Est. Return
TIM
Tortoise Investment Management White Plains, New York $1.21B AUM 13.04% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
GC
Gillson Capital Chicago, Illinois $1.22B AUM 7.54% 1-Year Est. Return
LWIC
Leith Wheeler Investment Counsel Vancouver, British Columbia, Canada $1.21B AUM 12.04% 1-Year Est. Return

Kimelman & Baird's Q1 2026 Portfolio in Review

As of Q1 2026, Kimelman & Baird held 275 positions worth $1.22B, down 6.6% from $1.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Kimelman & Baird's Q1 2026 filing shows 12 new, 27 increased, 50 reduced and 12 closed positions. Its largest new stake was Travelers Companies: 8,514 shares worth $2.48M. The largest sale was Norfolk Southern, an estimated $16.9M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

  • Kimelman & Baird's largest Q1 2026 buy was Travelers Companies: 8,514 shares worth $2.48M.
  • Kimelman & Baird added most to Regeneron Pharmaceuticals in Q1 2026, an estimated $8.07M increase.
  • Kimelman & Baird's biggest Q1 2026 reduction was Norfolk Southern, cutting an estimated $16.9M.
  • Kimelman & Baird fully exited Exact Sciences in Q1 2026, selling an estimated $203K.
  • Kimelman & Baird's ten largest holdings make up 43% of its $1.22B portfolio in Q1 2026.
  • Kimelman & Baird opened 12 new positions and closed 12 in Q1 2026.
  • Kimelman & Baird's portfolio value fell 6.6% quarter-over-quarter to $1.22B.

Based on Kimelman & Baird's 13F filing for Q1 2026, filed 13 May 2026.